August 29, 2019 | Alert | By Bruce Sokler, Farrah Short
Read about Third Point and three funds’ agreement to pay $609,810 to settle HSR Act antitrust allegations related to their delayed reporting of securities acquired due to the merger of third parties.
June 13, 2019 | Alert | By Bruce Sokler, Farrah Short
Read about Canon Inc. and Toshiba Corporation’s agreement to pay $2.5 million each to settle DOJ antitrust allegations associated with a $6.1 billion transaction.
May 31, 2019 | Alert | By Bruce Sokler, Farrah Short
This alert discusses State of Washington v. Franciscan Health System, outlines its proposed settlement, and reviews the important takeaways for health care provider affiliations.
May 24, 2019 | Blog | By Michael Renaud, Bruce Sokler, Rich Gervase, Harold Laidlaw
Just when observers thought Qualcomm could celebrate its successful litigation with Apple another decision has come down which could have major implications for Qualcomm’s business going forward.
Hospital Plaintiff’s Reliance on a Per Se Antitrust Claim against Dominant Competitor Fails in Sixth Circuit Despite Defeat of a Copperweld Defense
May 2, 2019 | Alert | By Bruce Sokler, Robert Kidwell, Farrah Short
Read about the Sixth Circuit's rejection of a hospital plaintiff’s per se antitrust claim against a dominant competitor in The Medical Center at Elizabeth Place, LLC v. Atrium Health System.
April 29, 2019 | Alert | By Bruce Sokler, Evelyn French
April 12, 2019 | Video | By Robert Kidwell
Rob Kidwell provides an overview of the Committee on Foreign Investment in the United States (CFIUS) and the recent amendments to the statute governing the committee as well as how these changes impact business transactions.
April 12, 2019 | Video | By Bruce Sokler
Bruce Sokler discusses the consent decree that resolved the Department of Justice’s attack against Atrium Health in which the DOJ challenged Atrium’s use of anti-steering provisions in their contracts with insurers.
March 20, 2019 | Alert | By Bruce Sokler, Farrah Short
This alert from the Mintz health care antitrust team outlines the reasoning behind a California court’s March 14, 2019 decision against Sutter Health — a case involving claims of alleged price tampering and combination to monopolize.
DOJ Antitrust Division Makes Filings in Civil Cases to Influence Development of Antitrust “No Poach” Law
March 12, 2019 | Alert | By Bruce Sokler, Farrah Short
This antitrust alert highlights two filings made by the DOJ last week in cases pending in federal district courts in North Carolina and Washington.
February 19, 2019 | Alert | By Bruce Sokler, Robert Kidwell, Farrah Short
Read about the FTC’s new “size of transaction” and “size of person” thresholds requiring reporting under the Hart-Scott-Rodino Antitrust Improvements Act of 1976.
February 4, 2019 | Advisory | By Bruce Sokler, Robert Kidwell, Farrah Short
Read about FTC commissioners’ divergent views on vertical mergers detailed in statements filed with a proposed consent order regarding Staples’ acquisition of Essendant.
December 14, 2018 | Alert | By Bruce Sokler, Farrah Short
Read about the 11th Circuit's denial of Blue Cross Blue Shield’s appeal of a ruling that its allegedly restrictive practices must be analyzed under the per se standard.
December 7, 2018 | Alert | By Bruce Sokler, Farrah Short
This alert reviews the DOJ’s Competitive Impact Statement on the Atrium case, which suggests that providers including anticompetitive steering restrictions in payor contracts may face antitrust risks.
DOJ Reaches Proposed Settlement in Anti-Steering Case Against Atrium Health (f/k/a Carolinas HealthCare)
November 15, 2018 | Alert | By Bruce Sokler, Farrah Short
Read about a DOJ Antitrust Division proposed settlement that would bar Atrium Health from using anticompetitive steering restrictions in payor contracts.
October 30, 2018 | Alert | By Bruce Sokler, Shawn Skolky
This antitrust alert outlines an FTC settlement designed to reduce anticompetitive effects resulting from the merger of gas suppliers Praxair, Inc. and Linde AG.
October 4, 2018 | Alert | By Bruce Sokler, Shawn Skolky
Read about a US District Court’s denial of Landmark Theaters’ dismissal motion in an exclusive dealing Sherman Act antitrust case brought by independent movie theaters.
Head of the Antitrust Division of the Department of Justice Announces Plan to Expedite the Merger Review Process and Put DOJ on a 6 Month Shot Clock
October 2, 2018 | Advisory | By Bruce Sokler, Evelyn French
In September 25, 2018 remarks at the 2018 Global Antitrust Enforcement Symposium, Assistant Attorney General Makan Delrahim announced the Department of Justice’s plan to modernize and expedite the DOJ merger review process. This article outlines the changes to the merger review process, which the DOJ now plans to complete within six months of the parties’ Hart-Scott-Rodino filings.
August 31, 2018 | Alert | By Bruce Sokler, Farrah Short
The Third Circuit reinstated an antitrust suit brought by a medical device seller that alleged Blue Cross Blue Shield Association and five of its member insurance plan administrators shut out the seller by conspiring to deny coverage for its device. LifeWatch Services Inc. v. Highmark Inc. et al., Case No. 17-1990 (3rd Cir. Aug. 28, 2018). Critical to the Third Circuit’s reversal of the lower court’s dismissal of the suit was market definition. In this buyer-side conspiracy case, where the seller alleged a concerted refusal to deal by purchasers of its product, the relevant market is comprised of buyers who are seen by the seller as reasonably good substitutes for each other regarding the purchase of its product. Thus “[a] concerted refusal to deal with all sellers of telemetry monitors, regardless of its equality, may still restrain competition in the alleged market for the purchase of outpatient cardiac monitors.” The lower court had instead focused on the market for the seller’s product.
May 16, 2018 | Alert | By Bruce Sokler, Robert Kidwell, Farrah Short
The Premerger Notification Office (the “PNO”) of the Federal Trade Commission (the “FTC”) recently issued a reminder about often overlooked “transactions” that may require notification under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the “HSR Act”).
Explore Other Viewpoints:
- Arbitration, Mediation & Alternate Dispute Resolution
- Bankruptcy & Restructuring
- Class Action
- Complex Commercial Litigation
- Consumer Product Safety
- Debt Financing
- EB-5 Financing
- Education & Nonprofits
- Employment, Labor & Benefits
- Energy & Sustainability
- Environmental Enforcement Defense
- Environmental Law
- FDA Regulatory
- Federal Circuit Appeals
- Financial Institution Litigation
- Government Law
- Health Care
- Health Care Compliance, Fraud and Abuse, & Regulatory Counseling
- Health Care Enforcement & Investigations
- Health Care Transactions
- Health Information Privacy & Security
- IP Due Diligence
- IPRs & Other Post Grant Proceedings
- Insolvency & Creditor Rights Litigation
- Institutional Investor Class Action Recovery
- Insurance & Financial Services
- Insurance Consulting & Risk Management
- Insurance and Reinsurance Problem-Solving & Dispute Resolution
- Intellectual Property
- Investment Funds
- Licensing & Technology Transactions
- Life Sciences
- Litigation & Investigations
- M&A Litigation
- ML Strategies
- Medicare, Medicaid and Commercial Coverage & Reimbursement
- Mergers & Acquisitions
- Patent Litigation
- Patent Prosecution & Strategic Counseling
- Privacy & Cybersecurity
- Private Client
- Private Equity
- Products Liability & Complex Tort
- Project Development & Finance
- Public Finance
- Real Estate Litigation
- Real Estate Transactions
- Real Estate, Construction & Infrastructure
- Retail & Consumer Products
- Securities & Capital Markets
- Securities Litigation
- Sports & Entertainment
- Strategic IP Monetization & Licensing
- Trade Secrets
- Trademark & Copyright
- Trademark Litigation
- Venture Capital & Emerging Companies
- White Collar Defense & Government Investigations